pneumonia
seriou
ill
implic
lead
caus
morbid
mortal
influenza
pneumonia
ninth
caus
mortal
unit
state
murphi
xu
kochanak
approxim
million
case
pneumonia
cap
annual
averag
patient
requir
hospit
cap
lead
caus
death
infecti
diseas
mortal
increas
mortal
patient
hospit
sever
diseas
genn
et
al
mani
patient
hospit
treatment
cap
deadli
diseas
health
promot
strategi
risk
stratif
treatment
option
use
lower
rate
hospit
admiss
relat
cap
nurs
practition
np
frontlin
primari
care
make
critic
differ
implement
health
promot
strategi
aim
decreas
overal
pneumonia
rate
furthermor
np
use
risk
stratif
tool
decid
good
candid
outpati
therapi
cap
accord
nation
center
health
statist
hospit
discharg
pneumonia
unit
state
approxim
million
annual
averag
hospit
stay
day
annual
number
death
result
pneumonia
death
per
us
popul
pneumonia
account
inpati
death
nation
center
health
statist
main
caus
death
relat
cap
complic
sepsi
multiorgan
failur
refractori
hypoxemia
shock
restrepo
anzueto
estim
cost
treat
cap
per
year
unit
state
approxim
billion
dollar
asch
seal
crookston
mullin
inpati
treatment
approxim
time
much
outpati
care
labarer
et
al
hospit
cap
averag
cost
care
per
incid
lutfiyya
henri
chang
reyburn
restrepo
anzueto
cost
outpati
treatment
much
less
may
littl
per
patient
lutfiyya
et
al
individu
risk
cap
includ
smoke
comorbid
condit
antibiot
treatment
hospit
within
past
month
comorbid
condit
includ
asthma
lung
cancer
chronic
obstruct
pulmonari
diseas
diabet
alcohol
chronic
renal
diseas
liver
failur
heart
failur
malnutrit
human
immun
defici
viru
chronic
steroid
use
center
diseas
control
prevent
cdc
mandel
et
al
accord
mandel
et
al
elderli
risk
cap
increas
number
comorbid
decreas
mucociliari
clearanc
diminish
cough
reflex
increas
incid
aspir
increas
colon
organ
depress
immun
system
alcohol
increas
cap
risk
cough
suppress
increas
colon
organ
immun
suppress
cigarett
smoke
long
known
risk
factor
cap
impair
mucociliari
action
macrophag
activ
mandel
et
al
pneumonia
infect
lung
organ
bacteria
fungi
virus
typic
start
colon
offend
organ
nasopharyng
area
also
occur
infecti
droplet
directli
inhal
secondari
infect
sepsi
bacteremia
host
alter
protect
mechan
impair
ciliari
action
product
mucou
immobl
immun
defici
higher
risk
develop
cap
organ
enter
alveoli
lung
immun
respons
trigger
brasher
chesnutt
prendergast
ranganathan
sonnappa
type
virul
offend
organ
part
determin
extent
immun
respons
mild
sever
organ
low
virul
typic
engulf
macrophag
set
mild
immun
respons
offend
organ
great
number
highli
virul
seri
immun
respons
occur
includ
releas
inflammatori
mediat
cellular
infiltr
immun
activ
involv
immun
respons
symptomat
patient
becom
brasher
chesnutt
prendergast
ranganathan
sonnappa
virus
caus
primari
pneumonia
predispos
infect
individu
secondari
bacteri
pneumonia
presenc
virus
initi
immun
respons
also
damag
host
destroy
ciliat
epitheli
cell
goblet
cell
bronchial
epithelium
natur
weaken
host
defens
bronchial
epithelium
slough
presenc
diminish
mucociliari
clearanc
decreas
clearanc
pulmonari
secret
creat
perfect
breed
ground
host
bacteria
lead
secondari
bacteri
infect
brasher
patient
becom
symptomat
bodi
respons
invad
organ
destruct
cell
viral
organ
andor
releas
toxin
bacteri
cell
wall
white
blood
cell
chemic
immun
system
arriv
site
invad
organ
fill
alveoli
lung
impair
oxygen
produc
symptom
typic
pneumonia
cough
hypoxia
fever
chill
tachypnea
fatigu
malais
brasher
chesnutt
prendergast
ranganathan
sonnappa
cap
one
five
classif
pneumonia
defin
acut
infect
pulmonari
parenchyma
acquir
commun
set
meet
criteria
cap
patient
must
hospit
within
day
onset
symptom
must
within
day
hospit
must
resid
care
facil
nazarian
eddi
luken
weingart
decker
mani
case
pneumonia
caus
organ
identifi
success
empir
treatment
risk
stratif
test
caus
organ
typic
reserv
patient
higher
acuiti
ill
cap
restrepo
anzueto
enough
research
carri
date
identifi
common
organ
cap
interestingli
enough
common
etiolog
cap
vari
depend
sever
ill
mandel
et
al
exampl
risk
stratif
acuiti
ill
help
guid
treatment
bacteri
atyp
bacteri
pathogen
commonli
respons
cap
patient
stabl
enough
treat
outpati
includ
streptococcu
pneumonia
haemophilu
influenza
chlamydophila
pneumonia
moraxella
catarrhali
mycoplasma
pneumonia
brasher
respiratori
virus
also
caus
cap
outpati
popul
includ
virus
influenza
b
adenoviru
respiratori
syncyti
viru
parainfluenza
viru
mandel
et
al
kereszt
individu
cap
ill
enough
requir
hospit
nonintens
care
unit
icu
environ
commonli
infect
similar
organ
outpati
cap
addit
legionella
pneumophila
anaerob
associ
aspir
etiolog
ill
sever
ill
cap
patient
requir
icu
admiss
commonli
infect
pneumonia
h
influenza
staphylococcu
aureu
l
pneumophila
gram
neg
bacilli
mandel
et
al
plouff
martin
patient
disposit
base
sever
ill
help
initi
subsequ
treatment
patient
hospit
cap
patient
cap
often
seen
first
primari
care
urgent
care
emerg
room
provid
symptom
classic
present
includ
cough
fever
chest
pain
tachypnea
dyspnea
less
obviou
present
respiratori
symptom
mental
statu
chang
unexplain
arthralgia
myalgia
sever
case
may
present
alter
level
conscious
sepsi
respiratori
failur
addit
constitut
symptom
may
includ
fatigu
headach
malais
nausea
vomit
mandel
et
al
plouff
martin
thorough
histori
essenti
diagnosi
manag
cap
initi
compon
histori
explor
onset
present
symptom
locat
primari
symptom
durat
ill
charact
cough
sputum
pain
aggrav
factor
reliev
factor
treatment
tri
patient
rate
sever
ill
pain
alert
symptom
potenti
cap
complaint
dyspnea
orthopnea
fatigu
weak
confus
neg
symptom
test
result
help
posit
one
evalu
cap
versu
differenti
diseas
presenc
absenc
chest
pain
weight
gain
edema
abdomin
pain
dysuria
hematuria
neurolog
symptom
help
clinician
arriv
appropri
diagnosi
patient
histori
essenti
arriv
diagnosi
cap
histor
data
influenc
compon
physic
assess
develop
diagnosi
creation
holist
treatment
plan
specif
patient
list
current
medic
allergi
also
elicit
includ
prescript
counter
therapi
herbal
remedi
addit
histor
element
miss
includ
past
medic
famili
social
health
mainten
histori
past
medic
histori
survey
chronic
diseas
autoimmun
ill
cancer
chronic
respiratori
ill
recent
acut
ill
recent
hospit
famili
histori
includ
assess
acut
ill
household
chronic
respiratori
diseas
eg
tuberculosi
chronic
tobacco
use
home
element
social
histori
includ
patient
use
tobacco
alcohol
occup
exposur
lung
irrit
narcot
illicit
drug
use
ascertain
case
cap
versu
classif
pneumonia
also
import
assess
place
resid
home
institut
assist
live
facil
nurs
home
homeless
shelter
health
mainten
histori
includ
immun
statu
influenza
pneumovax
shot
physic
exam
give
clue
diagnosi
cap
acut
ill
may
contribut
develop
cap
upon
initi
observ
confus
weak
short
breath
may
note
key
exam
compon
includ
limit
vital
sign
gener
survey
head
eye
ear
nose
throat
heent
neck
chest
respiratori
cardiac
skin
mental
statu
cap
may
affect
vital
sign
includ
fever
tachypnea
tachycardia
hypotens
hypoxia
gener
survey
may
reflect
appear
fatigu
ill
impair
level
conscious
thorough
physic
assess
give
evid
pneumonia
heent
exam
may
show
sign
upper
respiratori
infect
otiti
media
nasal
congest
discharg
sinu
tender
ocular
discharg
pharyng
erythema
without
exud
evid
respiratori
distress
may
includ
mouth
breath
nasal
flare
grunt
dehydr
common
complic
acut
ill
evidenc
eye
ear
nose
throat
exam
dull
eye
dri
lip
buccal
mucosa
cap
ill
affect
mani
system
bodi
abnorm
neck
exam
cap
patient
may
includ
lymphadenopathi
carotid
bruit
jugular
venou
distens
assess
rule
diseas
process
respons
complic
present
symptom
chest
exam
may
reveal
intercost
retract
accessori
muscl
use
dull
percuss
increas
tactil
fremitu
egophoni
bronchophoni
promin
whisper
pectoriloquy
chest
tender
help
identifi
area
lung
consolid
find
auscult
may
includ
diminish
lung
sound
wheez
crackl
rhonchi
combin
adventiti
sound
oxygen
satur
level
detect
hypoxia
indic
sever
ill
obtain
part
vital
sign
addit
system
affect
cap
may
includ
cardiac
skin
mental
statu
cardiac
exam
may
show
tachycardia
evid
poor
perfus
prolong
capillari
refil
heart
sound
point
maxim
impuls
note
indic
congest
heart
failur
differenti
cap
abdomen
assess
musculoskelet
neurolog
system
gain
inform
gener
condit
patient
skin
may
poor
turgor
tent
dehydr
addit
cyanosi
hypoxia
mental
statu
show
evid
confus
hypoxia
present
cap
straightforward
subtl
complex
differenti
diagnos
consid
confront
sign
symptom
cap
includ
exacerb
chronic
obstruct
pulmonari
diseas
central
nervou
system
diseas
inhal
injuri
reactiv
airway
diseas
bronchiti
influenza
lung
cancer
pulmonari
embolu
congest
heart
failur
tuberculosi
myocardi
infarct
atelectasi
empyema
chesnutt
prendergast
plouff
martin
tabl
compar
common
differenti
consid
diagnosi
cap
thorough
histori
physic
diagnost
find
help
differenti
cap
potenti
ill
cap
suspect
chest
radiograph
obtain
possibl
infiltr
chest
confirm
diagnosi
pneumonia
type
infiltr
help
clinician
differenti
viral
bacteri
pneumonia
interstiti
infiltr
common
viral
pneumonia
alveolar
infiltr
suggest
bacteri
pneumonia
viral
bacteri
pneumonia
occur
simultan
clinician
may
see
varieti
present
chest
reli
assess
find
clinic
judgment
risk
stratif
determin
best
treatment
ruuskanen
lahti
jen
murdoch
chest
also
help
evalu
resolut
infect
identif
lung
diseas
underli
ill
neoplasm
radiolog
evid
cap
resolv
within
week
chesnutt
prendergast
accord
mandel
et
al
cap
follow
repeat
chest
week
symptom
resolut
rule
underli
clinic
patholog
complet
blood
count
obtain
patient
suspect
cap
regardless
sever
accord
plouff
martin
patient
determin
mild
cap
treat
home
need
addit
laboratori
data
sputum
cultur
use
identifi
caus
organ
cap
collect
sampl
good
qualiti
mean
sputum
specimen
deep
cough
cultur
within
h
obtain
cultur
aspir
thoracentesi
obtain
found
signific
chest
blood
cultur
necessari
patient
stabl
enough
treat
outpati
basi
inpati
cap
blood
cultur
also
urin
test
antigen
l
pneumophila
pneumonia
file
mandel
et
al
psi
risk
model
creat
investig
larg
cap
cohort
studi
classifi
risk
patient
cap
tool
psi
valid
sever
larg
investig
set
nurs
home
emerg
depart
commun
hospit
psi
found
effect
determin
sever
pneumonia
need
hospit
psi
well
support
literatur
consid
potenti
tool
risk
stratif
determin
patient
appropri
treatment
outpati
set
lutfiyya
et
al
nazarian
et
al
psi
evalu
risk
assess
individu
patient
characterist
includ
demograph
comorbid
physic
exam
find
laboratori
radiograph
find
demograph
risk
includ
gender
nurs
home
resid
score
comorbid
includ
neoplasm
liver
diseas
heart
failur
stroke
renal
failur
physic
exam
find
pertin
psi
score
system
includ
mental
statu
respiratori
rate
systol
blood
pressur
temperatur
puls
laboratori
radiograph
find
assess
psi
includ
arteri
ph
blood
urea
nitrogen
sodium
glucos
hematocrit
partial
pressur
arteri
oxygen
pleural
effus
ebel
psi
risk
classif
serv
guid
outpati
versu
inpati
treatment
psi
score
place
risk
class
base
number
point
accumul
patient
risk
classif
ii
point
consid
safe
treat
outpati
basi
risk
class
iii
point
manag
outpati
need
close
clinic
observ
np
patient
psi
score
iv
v
point
patient
need
hospit
pneumonia
treatment
ebel
lutfiyya
et
al
carratala
et
al
studi
outcom
patient
psi
class
ii
iii
found
statist
signific
differ
patient
outcom
treat
inpati
versu
outpati
although
assum
inpati
care
lead
better
outcom
studi
show
hospit
place
patient
risk
complic
phlebiti
pulmonari
embol
carratala
et
al
p
anoth
studi
psi
labarer
et
al
show
low
risk
individu
cap
treat
outpati
return
usual
activ
work
day
sooner
low
risk
patient
hospit
quicker
assess
much
use
tool
point
care
simplic
use
includ
five
variabl
compar
psi
also
provid
substitut
use
blood
test
immedi
avail
ebel
p
clinic
factor
score
includ
confus
bun
respiratori
rate
blood
pressur
age
ebel
score
rang
individu
score
consid
low
risk
treat
outpati
score
may
requir
close
outpati
observ
short
inpati
hospit
depend
clinician
judgment
patient
circumst
patient
psychosoci
circumst
inabl
follow
direct
lack
social
support
transport
may
benefit
brief
inpati
stay
patient
score
greater
candid
inpati
hospit
ebel
accord
et
al
psi
accur
identifi
patient
sever
ill
includ
highest
risk
mortal
within
day
may
need
icu
admiss
elderli
good
tool
outpati
set
laboratori
data
immedi
avail
inpati
treatment
cap
expens
compar
outpati
treatment
would
signific
cost
save
healthcar
provid
appropri
util
psi
sever
scale
identifi
suitabl
patient
outpati
treatment
psi
assess
tool
access
http
ebel
idsaat
guidelin
summar
tabl
includ
recent
recommend
treatment
cap
empir
antibiot
macrolid
first
line
treatment
healthi
individu
antibiot
use
last
month
doxycyclin
also
use
popul
altern
macrolid
antibiot
classif
cover
common
atyp
organ
pneumonia
chlamydia
pneumonia
mandel
et
al
use
fluoroquinolon
treat
ambulatori
patient
cap
without
comorbid
condit
risk
factor
drsp
recent
antimicrobi
use
discourag
concern
widespread
use
may
lead
develop
fluoroquinolon
resist
mandel
et
al
p
patient
taken
antibiot
within
last
month
comorbid
chronic
heart
lung
liver
renal
diseas
diabet
asplenia
alcohol
malign
immunocompromis
treatment
includ
fluoroquinolon
gemifloxacin
moxifloxacin
levofloxacin
amoxicillin
plu
macrolid
azithromycin
doxycyclin
amoxicillin
use
patient
high
risk
drsp
popul
risk
includ
year
famili
member
employe
expos
children
day
care
set
recipi
therapi
within
last
month
person
alcohol
comorbid
immunocompromis
individu
live
region
high
rate
greater
high
level
macrolid
resist
pneumonia
also
treat
respiratori
fluoroquinolon
plu
macrolid
doxycyclin
cephalosporin
ceftriaxon
cefpodoxim
cefuroxim
may
use
altern
amoxicillin
amoxicillin
allergi
present
mandel
et
al
identifi
local
clinician
region
high
rate
drug
resist
np
contact
local
laboratori
obtain
current
antiobiogram
inform
resist
rate
commun
antiobiogram
chart
indic
organ
demonstr
resist
particular
local
hannigan
tolman
larson
p
antivir
research
sinc
outbreak
found
decreas
mortal
rate
initi
quickli
patient
viral
pneumonia
combin
pneumonia
cdc
minakami
et
al
yang
et
al
although
pediatr
guidelin
includ
use
antivir
treatment
cap
current
guidelin
use
antivir
adult
popul
evid
becom
avail
antivir
oseltamivir
andor
zanamivir
may
becom
standard
care
initi
treatment
cap
suspicion
viral
pneumonia
high
even
use
antivir
np
care
assess
symptom
secondari
bacteri
pneumonia
antibiot
initi
appropri
tabl
outlin
antimicrobi
select
base
frequent
etiolog
pneumonia
includ
viral
infect
antimicrobi
treatment
cap
antipyret
ibuprofen
acetaminophen
use
fever
malais
associ
cap
system
corticosteroid
use
patient
reactiv
airway
symptom
cap
steroid
treatment
individu
cap
without
reactiv
airway
symptom
controversi
lack
evid
efficaci
date
brown
dean
addit
therapi
may
includ
use
bronchodil
cough
suppress
adequ
nutrit
hydrat
bronchodil
may
need
use
open
airway
inflam
cytokin
releas
cap
restrepo
anzueto
prescript
cough
suppress
gener
recommend
use
judici
individu
unabl
sleep
signific
cough
encourag
adequ
fluid
intak
also
import
avoid
dehydr
facilit
clearanc
secret
good
nutrit
also
recommend
provid
adequ
nutrient
requir
facilit
heal
cap
support
bodi
immun
respons
outpati
cap
gener
h
initi
diagnosi
week
patient
alway
instruct
seen
sooner
complic
concern
develop
individu
tobacco
smoker
also
seen
week
repeat
evalu
repeat
chest
rule
underli
patholog
could
contribut
cap
health
promot
diseas
prevent
strategi
smoke
cessat
immun
judici
use
antibiot
success
decreas
mortal
hospit
rate
cap
accord
cdc
cap
decreas
seventh
lead
caus
death
ninth
lead
caus
death
unit
state
retrospect
review
data
avail
hcupnet
show
decreas
rate
hospit
cap
person
annual
compar
data
report
avail
agenc
healthcar
research
qualiti
healthcar
util
project
hcup
databas
compil
nation
data
state
data
organ
hospit
associ
privat
data
organ
feder
govern
hcup
includ
larg
collect
longitudin
hospit
care
data
unit
state
includ
data
hospit
rate
pneumonia
zagaria
discuss
lack
clinic
evid
smoke
cessat
reduc
pneumonia
rate
understand
smoke
alon
increas
risk
death
make
logic
conclus
smoke
cessat
reduc
risk
cap
smoke
cessat
import
risk
reduct
strategi
pneumonia
diseas
qualiti
measur
use
joint
commiss
center
medicar
medicaid
servic
shorr
owen
also
focu
patient
protect
portabl
care
act
sign
law
presid
obama
may
franken
new
healthcar
act
increas
patient
access
health
care
also
focus
health
care
reform
emphasi
diseas
prevent
health
promot
like
never
unit
state
accord
franken
health
reform
work
multipl
level
prevent
ill
interven
earli
risk
ill
occur
help
chronic
ill
becom
sicker
gener
keep
american
healthier
longer
p
focu
reduc
prevent
death
tobacco
use
one
healthcar
reform
strategi
possibl
adequ
fund
legisl
franken
impact
tobacco
use
well
studi
document
year
cessat
strategi
cessat
strategi
studi
found
increas
success
get
patient
stop
smoke
includ
healthcar
provid
screen
tobacco
use
use
electron
medic
record
emr
remind
system
health
mainten
flow
sheet
follow
support
patient
educ
identifi
patient
tobacco
user
first
step
address
seriou
risk
factor
patient
routin
visit
atherton
car
meyer
boyl
solberg
fior
hess
healthcar
provid
provid
educ
support
pharmacolog
intervent
assist
patient
smoke
cessat
new
era
healthcar
reform
support
emr
make
cessat
strategi
np
strive
adher
best
practic
effici
past
exampl
enrol
identifi
tobacco
user
program
offer
support
cessat
resourc
servic
invit
encourag
patient
contempl
commit
smoke
cessat
atherton
et
al
boyl
et
al
hess
pneumovax
vaccin
mean
protect
person
age
concurr
diseas
pneumonia
count
rehm
pneumonia
vaccin
offer
adult
year
older
individu
consid
high
risk
pneumonia
individu
includ
chronic
lung
diseas
diabet
heart
diseas
compromis
immun
system
pneumonia
vaccin
administ
individu
patient
age
boost
year
initi
immun
prevent
wane
immun
cdc
current
statist
pneumonia
vaccin
show
person
age
immun
cdc
accord
rosenburg
et
al
pneumococc
vaccin
reduc
incid
invas
pneumococc
diseas
children
less
year
also
addit
herd
effect
benefit
unvaccin
individu
decreas
nasopharyng
colon
vaccin
also
reduc
incid
older
adult
especi
women
transmiss
children
adult
normal
seen
winter
month
walter
taylor
dowel
mathi
moor
influenza
vaccin
shown
prevent
flu
individu
younger
year
age
administ
annual
miller
drinka
miller
drinka
found
influenza
vaccin
prevent
hospit
pneumonia
effect
prevent
death
nurs
home
resid
p
influenza
pneumonia
seventh
lead
caus
death
year
age
american
lung
associ
increas
risk
high
dose
influenza
vaccin
offer
adult
year
older
flu
season
cdc
clinician
encourag
vaccin
popul
earlier
season
immun
found
last
throughout
entir
season
vaccin
patient
august
septemb
allow
herd
immun
build
time
infect
begin
egg
allergi
restrict
also
lessen
patient
true
anaphylaxi
avoid
influenza
shot
patient
without
histori
anaphylaxi
egg
administ
vaccin
observ
min
clinic
set
long
clinic
equip
handl
anaphylact
emerg
inhal
nasal
influenza
vaccin
still
avoid
individu
egg
allergi
cdc
sever
research
initi
investig
health
promot
strategi
increas
immun
rate
pneumonia
influenza
vaccin
stand
immun
order
emr
remind
system
health
mainten
flow
sheet
patient
access
person
health
record
way
increas
immun
rate
therefor
decreas
risk
cap
provid
write
stand
immun
order
allow
nurs
immun
individu
patient
present
practic
flu
pneumonia
immun
without
need
expens
formal
offic
visit
allow
nurs
offer
immun
clinic
place
work
commun
zimmerman
et
al
emr
remind
system
prompt
nurs
healthcar
provid
point
care
regard
need
influenza
pneumonia
immun
individu
lack
immun
vaccin
immedi
system
also
use
provid
remind
mail
patient
due
immun
take
step
allow
patient
access
healthcar
summari
patient
portal
allow
evalu
health
promot
diseas
prevent
need
atherton
et
al
caligtan
dyke
dexheimera
et
al
nowalk
zimmerman
fegali
advent
emr
remind
system
patient
support
stand
order
use
tool
proven
increas
immun
rate
improv
smoke
cessat
rate
practic
even
presenc
increas
antibiot
resist
immun
risk
stratif
appropri
antibiot
use
contribut
declin
number
hospit
death
relat
pneumonia
literatur
show
key
decreas
hospit
admiss
overal
cost
cap
treatment
identifi
patient
low
risk
mortal
therebi
safe
treat
outpati
basi
determin
hospit
cap
difficult
multipl
factor
clinic
social
must
consid
increas
risk
mortal
associ
respiratori
rate
greater
diastol
hypotens
elev
blood
urea
nitrogen
level
johnston
majumdar
marri
p
risk
estim
vari
wide
provid
thought
variat
system
overestim
mortal
affect
hospit
admiss
rate
despit
cap
incid
johnston
et
al
np
initi
respond
help
identifi
prevent
treat
cap
effort
continu
support
downward
trend
hospit
admiss
low
risk
cap
unfortun
hospit
bacteri
pneumonia
continu
consum
larg
amount
healthcar
dollar
annual
spite
decreas
hospit
rate
length
stay
data
suggest
continu
room
avoid
deadli
diseas
aggress
outpati
prevent
manag
strategi
np
need
evalu
sever
pneumonia
use
tool
psi
use
sound
clinic
judgment
find
appropri
determin
candid
outpati
versu
inpati
treatment
use
establish
guidelin
atsidsa
promot
effect
therapi
use
research
allow
quicker
resolut
symptom
avoid
costli
hospit
admiss
pneumonia
prevent
identif
treatment
often
initi
famili
urgent
care
emerg
np
provid
role
abil
reduc
healthcar
cost
decreas
incid
cap
improv
patient
outcom
individu
cap
use
risk
stratif
appropri
antibiot
use
nation
improv
hospit
rate
cap
decad
use
strategi
risk
analysi
health
promot
judici
antibiot
use
current
healthcar
reform
stronger
focu
diseas
prevent
support
healthcar
provid
effort
continu
downward
trend
hospit
relat
cap
outpati
treatment
appropri
shown
return
patient
back
normal
activ
much
sooner
np
often
frontlin
care
mean
prevent
treat
cap
thu
improv
patient
outcom
healthcar
cost
